img

Fosun Pharma

img
Adhering to the business philosophy of “Innovation for Good Health”, Fosun Pharma and its subsidiaries (“Fosun Pharma Group”) are striving to become a first-tier enterprise in the global mainstream pharmaceutical and healthcare market. In 1994, the predecessor of Fosun Pharma was founded, and was listed on the SSE four years later. In 2004, its predecessor officially changed its name to Shanghai Fosun Pharmaceutical (Group) Co., Ltd. In 2005, Fosun Pharma was among the first group of Chinese A-share listed companies included in the CSI 300 Index. In the same year, Fosun Pharma’s research center was accredited as a national-level research center. In 2012, Fosun Pharma was listed on the Main Board of the Hong Kong Stock Exchange. As at the end of the 2020 Reporting Period, the Group held 38.62% equity interest in Fosun Pharma.
click here to corporate website
img

Shanghai Henlius

img
Shanghai Henlius actively implemented the concept of excellent commercialization, in order to create a complete value chain covering R&D, production and traditional commercialization. Based on the needs of patients and beginning with the end in mind, Shanghai Henlius has achieved a commercialization strategy of “focusing on product portfolio, manufacturing capacity and commercial operations to become the leader in biological medicine in China”. Shanghai Henlius was established in 2010 and listed on the Main Board of the Hong Kong Stock Exchange in September 2019. As at the end of the 2020 Reporting Period, the Group held 55.01% equity interest in Shanghai Henlius.
click here to corporate website
img

Gland Pharma

img
Gland Pharma is a pharmaceutical company primarily engaged in the manufacture of Small Volume Parenterals. Gland Pharma, founded in 1978, became the first company to set up pre-filled syringe facility in India in 1996 and the first Liquid Injectable Plant manufacturer approved by the U.S. Food and Drug Administration (“FDA”) in India in 2003. Gland Pharma introduced Heparin Sodium Injection, its flagship product, in the U.S. market in 2010. It has a consistent regulatory compliance track record and all its production facilities are approved by the FDA. Some of the other key regulatory agencies for which certain of its facilities have approvals include MHRA (UK), TGA (Australia), ANVISA (Brazil), AGES (Austria) and BGV (Germany).
click here to corporate website
img

Sisram Med

img
Sisram Med is a leading global provider of energy-based medical aesthetic treatment systems, with comprehensive in-house capability to design, develop and produce such systems, which feature its innovative and proprietary technologies. Brands including “Alma”, “Soprano”, “Harmony”, “ClearLift”, “Accent”, “FemiLift” and “BeautiFill” are widely recognized and well regarded among treatment providers and treatment recipients worldwide. Sisram Med also sells its treatment systems via distributors and direct sales to customers in over 90 countries and jurisdictions worldwide. As at the end of the 2020 Reporting Period, Fosun Pharma held 74.76% equity interest in Sisram Med.
click here to corporate website
img

Fosun Integrated Care (Shanghai Zhuli)

img
Fosun Integrated Care is a multi-level health and elderly care service brand established by the Group to achieve the “make every family healthier” vision and promote the innovation and services upgrade of health industry. Fosun Integrated Care is devoted to providing comprehensive, customized, competitive and innovative healthcare products and services to retired middle-class families in China. As at the end of the Reporting Period, Fosun Integrated Care held over 11,000 beds and total managed area of 530,000 square meters, with an occupancy rate of 97% for mature projects.
click here to corporate website
img

Fosun United Health Insurance

img
Fosun United Health Insurance was established in January 2017 with a registered capital of RMB500 million. Fosun United Health Insurance, as a professional health insurance company, was sponsored by the Group together with 5 other companies. As at the end of the Reporting Period, the Group held 20% equity interest in Fosun United Health Insurance. Fosun United Health Insurance is committed to providing high-quality health insurance products to customers. In the meantime, Fosun United Health Insurance actively explores the possibility to set up a health insurance pattern that can be operated with Chinese characteristics and devotes itself into the building of a digital and smart health service environment where the diversified health insurance and services can serve the needs of the clients.
click here to corporate website
img

Yuyuan

img
Relying on the urban cultural and commercial strength in Shanghai, Yuyuan, with the mission of creating a happy life for families worldwide, is determined to become the world’s first-class group in the family entertainment and consumption industry with roots in China, leading the trend of Chinese cultural revival. Yuyuan was formerly known as Shanghai Yuyuan Shopping Mall (上海豫园商场), which was transformed into Shanghai Yuyuan Shopping Mall Co., Ltd. (上海豫园商场股份有限公司) in June 1987. In May 1992, Shanghai Yuyuan Tourist Mart Co., Ltd. (上海豫园旅游商城股份有限公司) was established and its shares were listed on the SSE in September of the same year which officially changed its name to Shanghai Yuyuan Tourist Mart (Group) Co., Ltd. (上海豫园旅游商城(集团)股份有限公司) in July 2019. In November 2002, the Group became the largest shareholder of Yuyuan. As at the end of the 2020 Reporting Period, the Group held approximately 68.59% equity interest in Yuyuan.
click here to corporate website
img

Fosun Tourism Group

img
Fosun Tourism Group (‘FTG’) is one of the world’s leading leisure-focused integrated tourism groups, and the worldwide largest leisure tourism resorts group in terms of revenue in 2019 according to Frost & Sullivan Report. In 2015, the Group acquired control of Club Med and subsequently transferred it to FTG upon reorganization. FTG was officially established in 2016, and was spun off from the Group and successfully listed on the Main Board of the Hong Kong Stock Exchange in December 2018. As at the end of the 2020 Reporting Period, the Group held approximately 80.97% equity interest in FTG.
click here to corporate website
img

Fosun Insurance Portugal

img
In 2014, the Group established a subsidiary and acquired a controlling stake in Fidelidade, Multicare and Fidelidade Assistência. In September 2020, Multicare and Fidelidade Assistência were 100% held by Fidelidade after a reorganization of group structure and capital increase. As at the end of 2020 the Reporting Period, the Group held 84.9892% equity interest in Fidelidade. This platform is a leading player in the Portuguese insurance market and facilitates business development of the Group in Europe, Africa and Latin American countries.
click here to corporate website
img

Peak Reinsurance

img
Peak Reinsurance is a privately-owned global reinsurer headquartered in Hong Kong, established by the Group and International Finance Corporation in 2012. In April 2018, a wholly-owned subsidiary of U.S.-headquartered Prudential Financial, Inc. completed the acquisition of a minority stake in Peak Reinsurance Holdings Limited (“Peak Reinsurance Holdings”). As of the end of the 2020 Reporting Period, the Group held 86.51% equity interest in Peak Reinsurance through Peak Reinsurance Holdings.
click here to corporate website
img

Pramerica Fosun Life Insurance

img
Pramerica Fosun Life Insurance is a joint venture between the Group and The Prudential Insurance Company of America. With the approval of the regulatory authority, it was formally established in September 2012 and both shareholders hold 50% of the joint venture shares. The establishment of Pramerica Fosun Life Insurance marked the Group’s first entry into the domestic life insurance market.
click here to corporate website
img

Fosun Capital

img
Established in April 2007, Fosun Capital is an equity investment and management company, wholly owned by the Group. It is a leading private equity investment institute in the industry. As a first-class private equity fund manager in China, Fosun Capital provides highquality equity investment and management services to investors such as the well-known family funds, insurance companies, listed companies, large investment institutions and high net wealth individuals domestically and internationally.
click here to corporate website
img

Fosun RZ Capital

img
Fosun RZ Capital is the only global venture capital platform of the Group focusing on technology, internet and new consumption. It is also one of the investment institutions with the richest industrial resources in China. Fosun RZ Capital’s vision is to become a top investment institution that exploits its advantages as both an industrial platform and an independent fund to take root in China and cover major growing economic regions globally, with the aim of generating excellent investment returns and long-term strategic value for the Group.
click here to corporate website
img

Hauck Aufhäuser Lampe Privatbankiers AG (HAL)

img
Founded in 1796, HAL is headquartered in Frankfurt with offices in several key German cities such as Munich, Düsseldorf, Hamburg and Berlin. It also has branches in Luxembourg and London, a subsidiary in Zurich and a representative office in Paris. HAL announced its planned acquisition of Bankhaus Lampe KG in 2020. The transaction closed in September 2021 after the ownership control process was completed. Upon merger, Hauck & Aufhäuser Privatbank AG (“H&A”) was officially renamed Hauck Aufhäuser Lampe Privatbank AG (“HAL”) on 1 January 2022.
click here to corporate website
img

The Bund Finance Center (“BFC”)

img
Located at 600 Zhongshan No. 2 Road (E) (Postcode: 200010), Shanghai, China, with the Huangpu River to the east and Yuyuan Tourist Mart on the west, BFC is a benchmark project of Fosun’s “Hive City” and the only large ecological commercial complex located in the heart of the Bund. It embraced its grand opening on 12 December 2019. The gross floor area (“GFA”) of BFC is over 420,000 square meters. It integrates ecology with office, retail, catering, entertainment, health, art and tourism, opening a brand-new horizon of life in Shanghai.
click here to corporate website
img

Nanjing Iron & Steel

img
Nanjing Iron & Steel, a leading whole-process with high efficiency steel conglomerate. The improved production efficiency and product competitiveness through continuous technological innovation have enabled Nanjing Iron & Steel to form a unique competitive advantage of “high-efficiency production, low-cost intelligent manufacturing”, with the capability of producing 10 million tons of crude steel per year. As at the end of the 2020 Reporting Period, the Group held 58.81% equity interest in Nanjing Iron & Steel through Nanjing Nangang.
click here to corporate website
img

Hainan Mining

img
Established in August 2007, Hainan Mining was listed on the SSE in December 2014. ROC, the subsidiary of Hainan Mining, develops across the full range of upstream business activities in the oil and gas industry from exploration and appraisal of oil and gas to development and production. As at the end of the 2020 Reporting Period, the Group held 51.57% equity interest in Hainan Mining.
click here to corporate website
img

FFT

img
Founded in 1974, FFT is one of the world’s largest providers of intelligent manufacturing solutions. In May 2019, Shanghai FFT Automation Technology Co., Ltd. (上海愛夫迪自動化科技有限公司), a company invested by the Group, completed the acquisition of 100% equity interest in FFT.
click here to corporate website